Track the 에스디바이오센서 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has published 75 insider filings. Market capitalisation: €729.7bn. The latest transaction was filed on 24 March 2026 (Purchase). Among the most active insiders: 김석규. Every trade is openly available.
73
Insider Decl.
n/a
Thresholds
€2m
56 ops.
Buy Volume
n/a
12 ops.
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,467 of 29,062 companies
38.1
score / 100
Value
50
Quality
26
FCF yld41%
Earn yld-69%
EV/EBITDA·
ROE-27%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.